| GVI Joint Stock Company
Introduction
GVI Joint Stock Company was established on September 25, 2020 and operates under the Law on Enterprises of Vietnam. The headquarters of GVI is located at 19 Dinh Nup Street, Trung Hoa ward, Cau Giay District, Ha Noi, Vietnam.
Company name in Vietnamese: Công ty cổ phần GVI.
Company name in English: GVI Joint Stock Company.
Slogan: Reliable – Dynamic.
The main business areas:
– Distribution of health supplement.
– Distribution of cosmeceuticals.
– Distribution of supplies and electrical equipment.
– Providing smart home solutions.
– Consulting on the developing of smart city projects.
– Consulting and trade promotion.
– Investment in trading securities.
GVI has a team of skilled leaders, staff and collaborators, with a deep understanding of Vietnamese institutions, legal system and market.
GVI operates with the motto: Cooperation for mutual development, always being a reliable partner and only cooperating with partners that GVI trusts. Actively study and seek opportunities, alternatives and innovative and efficient resolutions that bring the highest benefits to partners and GVI.
News
See moreGVI provides Vimar switches and sockets for The Manor Central Park Nguyen Xien Project, Hanoi
In the last days of 2021, GVI Joint Stock Company accelerated the progress of the supply of vimar switches and sockets for The Manor Central Park. Perspective of The Manor Central Park Nguyen Xien Project This is a multifunctional urban area of the Investor is Bitexco Group & […]
Beta Glucan – scientifically proven potent anti-cancer agent
Cancer affects red blood cells, white blood cells, and platelets, weakening the body’s natural immune system. A proven cancer prevention method by researchers, Beta Glucan – a powerful anti-cancer agent that has the ability to trigger a defense response, strengthen the immune system. Beta Glucan – […]
4 effects of beta-glucan for diabetics to know
THE FIRST EFFECT OF BETA-GLUCAN FOR DIABETICS IS TO LOWER BLOOD SUGAR: In patients with type 2 diabetes, beta-glucan reduces blood sugar through inhibition of SGLT-1 receptors in the intestinal mucosa. This is a receptor that helps absorb sugar in the intestine, thereby inhibiting the absorption […]